Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Subscribe

Logo for

Mol. Cell. Biol. 20 (15): 5490-5502

Copyright © 2000 by the American Society for Microbiology. All rights reserved.

Molecular and Cellular Biology, August 2000, p. 5490-5502, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

HMG-I/Y, a New c-Myc Target Gene and Potential Oncogene

Lisa J. Wood,1,2 Mita Mukherjee,1,2 Christine E. Dolde,1,2 Yi Xu,1,2 Joseph F. Maher,3,dagger Tracie E. Bunton,4,Dagger John B. Williams,3 and Linda M. S. Resar1,2,3,5,*

Hematology Division1 and Departments of Pediatrics,2 Molecular Biology and Genetics,3 Comparative Medicine,4 and Oncology,5 The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205

Received 11 August 1999/Returned for modification 18 October 1999/Accepted 15 May 2000

The HMG-I/Y gene encodes the HMG-I and HMG-Y proteins, which function as architectural chromatin binding proteins important in the transcriptional regulation of several genes. Although increased expression of the HMG-I/Y proteins is associated with cellular proliferation, neoplastic transformation, and several human cancers, the role of these proteins in the pathogenesis of malignancy remains unclear. To better understand the role of these proteins in cell growth and transformation, we have been studying the regulation and function of HMG-I/Y. The HMG-I/Y promoter was cloned, sequenced, and subjected to mutagenesis analysis. A c-Myc-Max consensus DNA binding site was identified as an element important in the serum stimulation of HMG-I/Y. The oncoprotein c-Myc and its protein partner Max bind to this site in vitro and activate transcription in transfection experiments. HMG-I/Y expression is stimulated by c-Myc in a Myc-estradiol receptor cell line in the presence of the protein synthesis inhibitor cycloheximide, indicating that HMG-I/Y is a direct c-Myc target gene. HMG-I/Y induction is decreased in Myc-deficient fibroblasts. HMG-I/Y protein expression is also increased in Burkitt's lymphoma cell lines, which are known to have increased c-Myc protein. Like Myc, increased expression of HMG-I protein leads to the neoplastic transformation of both Rat 1a fibroblasts and CB33 cells. In addition, Rat 1a cells overexpressing HMG-I protein form tumors in nude mice. Decreasing HMG-I/Y proteins using an antisense construct abrogates transformation in Burkitt's lymphoma cells. These findings indicate that HMG-I/Y is a c-Myc target gene involved in neoplastic transformation and a member of a new class of potential oncogenes.

* Corresponding author. Mailing address: The Johns Hopkins University School of Medicine, Division of Pediatric Hematology, The Ross Research Bldg., Room 1125, 720 Rutland Ave., Baltimore, MD 21205. Phone: (410) 955-6132. Fax: (410) 955-8208. E-mail: lmsresar{at}welch.jhu.edu.

dagger Present address: University of Mississippi Medical Center/G. V. (Sonny) Montgomery Veterans Affairs Medical Center, Jackson, MS 39216.

Dagger Present address: DuPont Pharmaceutical Company, Stine-Haskell Research Center, Newark, DE 19714-0300.

Molecular and Cellular Biology, August 2000, p. 5490-5502, Vol. 20, No. 15
0270-7306/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
A Protein Array Screen for Kaposi's Sarcoma-Associated Herpesvirus LANA Interactors Links LANA to TIP60, PP2A Activity, and Telomere Shortening.
M. Shamay, J. Liu, R. Li, G. Liao, L. Shen, M. Greenway, S. Hu, J. Zhu, Z. Xie, R. F. Ambinder, et al. (2012)
J. Virol. 86, 5179-5191
   Abstract »    Full Text »    PDF »
Phase 1 and pharmacokinetic study of bolus-infusion flavopiridol followed by cytosine arabinoside and mitoxantrone for acute leukemias.
J. E. Karp, B. D. Smith, L. S. Resar, J. M. Greer, A. Blackford, M. Zhao, D. Moton-Nelson, K. Alino, M. J. Levis, S. D. Gore, et al. (2011)
Blood 117, 3302-3310
   Abstract »    Full Text »    PDF »
Widespread Genomic Instability Mediated by a Pathway Involving Glycoprotein Ib{alpha} and Aurora B Kinase.
Y. Li, F. L. Xu, J. Lu, W. S. Saunders, and E. V. Prochownik (2010)
J. Biol. Chem. 285, 13183-13192
   Abstract »    Full Text »    PDF »
The High Mobility Group A1 Gene: Transforming Inflammatory Signals into Cancer?.
L. M.S. Resar (2010)
Cancer Res. 70, 436-439
   Abstract »    Full Text »    PDF »
HMGA1 Levels Influence Mitochondrial Function and Mitochondrial DNA Repair Efficiency.
L. Mao, K. J. Wertzler, S. C. Maloney, Z. Wang, N. S. Magnuson, and R. Reeves (2009)
Mol. Cell. Biol. 29, 5426-5440
   Abstract »    Full Text »    PDF »
The High-Mobility Group A1a/Signal Transducer and Activator of Transcription-3 Axis: An Achilles Heel for Hematopoietic Malignancies?.
J. Hillion, S. Dhara, T. F. Sumter, M. Mukherjee, F. Di Cello, A. Belton, J. Turkson, S. Jaganathan, L. Cheng, Z. Ye, et al. (2008)
Cancer Res. 68, 10121-10127
   Abstract »    Full Text »    PDF »
Regulation of Calpain Activity by c-Myc through Calpastatin and Promotion of Transformation in c-Myc-negative Cells by Calpastatin Suppression.
M. Niapour, Y. Yu, and S. A. Berger (2008)
J. Biol. Chem. 283, 21371-21381
   Abstract »    Full Text »    PDF »
HMGA2 Participates in Transformation in Human Lung Cancer.
F. Di Cello, J. Hillion, A. Hristov, L. J. Wood, M. Mukherjee, A. Schuldenfrei, J. Kowalski, R. Bhattacharya, R. Ashfaq, and L. M.S. Resar (2008)
Mol. Cancer Res. 6, 743-750
   Abstract »    Full Text »    PDF »
Gemcitabine Resistance in Pancreatic Cancer: Picking the Key Players.
M. P. Kim and G. E. Gallick (2008)
Clin. Cancer Res. 14, 1284-1285
   Full Text »    PDF »
Transcriptional Control of the Human High Mobility Group A1 Gene: Basal and Oncogenic Ras-Regulated Expression.
I. Cleynen, C. Huysmans, T. Sasazuki, S. Shirasawa, W. Van de Ven, and K. Peeters (2007)
Cancer Res. 67, 4620-4629
   Abstract »    Full Text »    PDF »
The High-Mobility Group A1 Gene Up-Regulates Cyclooxygenase 2 Expression in Uterine Tumorigenesis.
A. Tesfaye, F. Di Cello, J. Hillion, B. M. Ronnett, O. Elbahloul, R. Ashfaq, S. Dhara, E. Prochownik, K. Tworkoski, R. Reeves, et al. (2007)
Cancer Res. 67, 3998-4004
   Abstract »    Full Text »    PDF »
p53 family proteins in thyroid cancer.
R Malaguarnera, V Vella, R Vigneri, and F Frasca (2007)
Endocr. Relat. Cancer 14, 43-60
   Abstract »    Full Text »    PDF »
HMGA1 Is a Determinant of Cellular Invasiveness and In vivo Metastatic Potential in Pancreatic Adenocarcinoma.
S.-S. Liau, A. Jazag, and E. E. Whang (2006)
Cancer Res. 66, 11613-11622
   Abstract »    Full Text »    PDF »
HMGA1 Inhibits the Function of p53 Family Members in Thyroid Cancer Cells..
F. Frasca, A. Rustighi, R. Malaguarnera, S. Altamura, P. Vigneri, G. Del Sal, V. Giancotti, V. Pezzino, R. Vigneri, and G. Manfioletti (2006)
Cancer Res. 66, 2980-2989
   Abstract »    Full Text »    PDF »
Molecular signatures in childhood acute leukemia and their correlations to expression patterns in normal hematopoietic subpopulations.
A. Andersson, T. Olofsson, D. Lindgren, B. Nilsson, C. Ritz, P. Eden, C. Lassen, J. Rade, M. Fontes, H. Morse, et al. (2005)
PNAS 102, 19069-19074
   Abstract »    Full Text »    PDF »
Deregulation of common genes by c-Myc and its direct target, MT-MC1.
K. R. Rogulski, D. E. Cohen, D. L. Corcoran, P. V. Benos, and E. V. Prochownik (2005)
PNAS 102, 18968-18973
   Abstract »    Full Text »    PDF »
Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein.
X.-y. Zhang, L. M. DeSalle, J. H. Patel, A. J. Capobianco, D. Yu, A. Thomas-Tikhonenko, and S. B. McMahon (2005)
PNAS 102, 13968-13973
   Abstract »    Full Text »    PDF »
Overexpression of NBS1 Contributes to Transformation through the Activation of Phosphatidylinositol 3-Kinase/Akt.
Y.-C. Chen, Y.-N. Su, P.-C. Chou, W.-C. Chiang, M.-C. Chang, L.-S. Wang, S.-C. Teng, and K.-J. Wu (2005)
J. Biol. Chem. 280, 32505-32511
   Abstract »    Full Text »    PDF »
High Mobility Group A1 Is a Molecular Target for MYCN in Human Neuroblastoma.
G. Giannini, F. Cerignoli, M. Mellone, I. Massimi, C. Ambrosi, C. Rinaldi, C. Dominici, L. Frati, I. Screpanti, and A. Gulino (2005)
Cancer Res. 65, 8308-8316
   Abstract »    Full Text »    PDF »
C-Myc-Independent Restoration of Multiple Phenotypes by Two C-Myc Target Genes with Overlapping Functions.
K. Rothermund, K. Rogulski, E. Fernandes, A. Whiting, J. Sedivy, L. Pu, and E. V. Prochownik (2005)
Cancer Res. 65, 2097-2107
   Abstract »    Full Text »    PDF »
Reexpression of p8 Contributes to Tumorigenic Properties of Pituitary Cells and Appears in a Subset of Prolactinomas in Transgenic Mice that Hypersecrete Luteinizing Hormone.
H. P. Mohammad, D. D. Seachrist, C. C. Quirk, and J. H. Nilson (2004)
Mol. Endocrinol. 18, 2583-2593
   Abstract »    Full Text »    PDF »
Casein Kinase II Alpha Subunit and C1-Inhibitor Are Independent Predictors of Outcome in Patients with Squamous Cell Carcinoma of the Lung.
P. O-charoenrat, V. Rusch, S. G. Talbot, I. Sarkaria, A. Viale, N. Socci, I. Ngai, P. Rao, and B. Singh (2004)
Clin. Cancer Res. 10, 5792-5803
   Abstract »    Full Text »    PDF »
HMG-I/Y Is a c-Jun/Activator Protein-1 Target Gene and Is Necessary for c-Jun-Induced Anchorage-Independent Growth in Rat1a Cells.
F. Hommura, M. Katabami, V. D. Leaner, H. Donninger, T. F. Sumter, L. M.S. Resar, and M. J. Birrer (2004)
Mol. Cancer Res. 2, 305-314
   Abstract »    Full Text »    PDF »
Direct Activation of HSP90A Transcription by c-Myc Contributes to c-Myc-induced Transformation.
S.-C. Teng, Y.-Y. Chen, Y.-N. Su, P.-C. Chou, Y.-C. Chiang, S.-F. Tseng, and K.-J. Wu (2004)
J. Biol. Chem. 279, 14649-14655
   Abstract »    Full Text »    PDF »
Expression of the High Mobility Group Proteins HMGI(Y) Correlates with Malignant Progression in Barrett's Metaplasia.
X. Chen, J. Lechago, A. Ertan, G. Ergun, R. Verm, M. Bridges, C. Johnson, K. Woods, F. Meriano, M. Chirala, et al. (2004)
Cancer Epidemiol. Biomarkers Prev. 13, 30-33
   Abstract »    Full Text »    PDF »
Transcriptional Activation of the Cyclin A Gene by the Architectural Transcription Factor HMGA2.
M. A. Tessari, M. Gostissa, S. Altamura, R. Sgarra, A. Rustighi, C. Salvagno, G. Caretti, C. Imbriano, R. Mantovani, G. Del Sal, et al. (2003)
Mol. Cell. Biol. 23, 9104-9116
   Abstract »    Full Text »    PDF »
HMGA1 protein over-expression is a frequent feature of epithelial ovarian carcinomas.
V. Masciullo, G. Baldassarre, F. Pentimalli, M. T. Berlingieri, A. Boccia, G. Chiappetta, J. Palazzo, G. Manfioletti, V. Giancotti, G. Viglietto, et al. (2003)
Carcinogenesis 24, 1191-1198
   Abstract »    Full Text »    PDF »
Embryonic Expression of the Luteinizing Hormone beta Gene Appears to Be Coupled to the Transient Appearance of p8, a High Mobility Group-related Transcription Factor.
C. C. Quirk, D. D. Seachrist, and J. H. Nilson (2003)
J. Biol. Chem. 278, 1680-1685
   Abstract »    Full Text »    PDF »
Targets of c-Jun NH2-terminal Kinase 2-mediated Tumor Growth Regulation Revealed by Serial Analysis of Gene Expression.
O. Potapova, S. V. Anisimov, M. Gorospe, R. H. Dougherty, W. A. Gaarde, K. R. Boheler, and N. J. Holbrook (2002)
Cancer Res. 62, 3257-3263
   Abstract »    Full Text »    PDF »
Myc Target in Myeloid Cells-1, a Novel c-Myc Target, Recapitulates Multiple c-Myc Phenotypes.
X. Yin, L. Grove, K. Rogulski, and E. V. Prochownik (2002)
J. Biol. Chem. 277, 19998-20010
   Abstract »    Full Text »    PDF »
Role of the high mobility group A proteins in human lipomas.
M. Fedele, S. Battista, G. Manfioletti, C. M. Croce, V. Giancotti, and A. Fusco (2001)
Carcinogenesis 22, 1583-1591
   Abstract »    Full Text »    PDF »
Critical Role of the HMGI(Y) Proteins in Adipocytic Cell Growth and Differentiation.
R. M. Melillo, G. M. Pierantoni, S. Scala, S. Battista, M. Fedele, A. Stella, M. C. De Biasio, G. Chiappetta, V. Fidanza, G. Condorelli, et al. (2001)
Mol. Cell. Biol. 21, 2485-2495
   Abstract »    Full Text »    PDF »
Architectural Transcription Factor HMGI(Y) Promotes Tumor Progression and Mesenchymal Transition of Human Epithelial Cells.
R. Reeves, D. D. Edberg, and Y. Li (2001)
Mol. Cell. Biol. 21, 575-594
   Abstract »    Full Text »    PDF »
The Oncogenic Properties of the HMG-I Gene Family.
L. J. Wood, J. F. Maher, T. E. Bunton, and L. M. S. Resar (2000)
Cancer Res. 60, 4256-4261
   Abstract »    Full Text »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882